American College of Gastroenterology

Charles Bernstein, MD, FACG, discusses his research on Inflammatory Bowel Disease (IBD) treatment at the 2014 ACG Annual Meeting in Philadelphia, PA.

Study results show significant regional variations in the types of procedures and tests administered and the number of prescriptions written for patients with irritable bowel syndrome (IBS), as well as in the number of emergency department visits and hospital admissions.

John Saltzman, MD, Director of Endoscopy, Brigham and Women's Hospital, shares his experiences and thoughts on endoscopy testing and other topics discussed at the 2014 ACG Annual Meeting in Philadelphia, PA.

John Saltzman, MD, discusses the gastrointestinal tract and the integration of novel gastrointestinal procedures into treatment, and the role of the human microbiome in relation to GI disorders.

In the era of rapidly improving cure rates for hepatitis C infection, has the importance of staging as part of treatment diminished?

Interim study results presented at ACG 2014 indicate that treatment with vedolizumab safely and effectively maintains long-term clinical remission and response in patients with Crohn's disease and ulcerative colitis.

The incidence of young-onset colorectal cancer is increasing, and the disease is more aggressive pathologically. These findings are being presented at the annual meeting of the American College of Gastroenterology, held from Oct. 17 to 22 in Philadelphia.

Study results indicate that diabetes mellitus is independently associated with the development of cirrhosis and hepatocellular carcinoma among patients who have fatty liver disease.

Results from a clinical trial designed to evaluate the effectiveness of a hepatitis C educational program delivered by the Hepatology Centers of Educational Expertise, a hepatologist-led working group dedicated to educating healthcare professionals on the latest developments in the management of chronic liver disease.

Case study results indicate boceprevir-based triple therapy could be a viable treatment option for patients with acute hepatitis C virus who fail to respond to standard treatment.

Study results show that patients currently taking opioids and those who were previously on chronic opioid therapy experienced induced esophageal dysfunction, with outflow obstruction and spastic esophageal dysmotility patterns more prevalent among current users.

Researchers report a cure rate of greater than 90 percent among patients with recurrent C. difficile infection treated with fecal microbiota transplantation at a community hospital.

Study results show that improvement in short-term mortality was seen in patients who receive corticosteroids for treatment of severe alcoholic hepatitis without an increased risk of infection occurrence.

A large majority of patients with chronic hepatitis C cleared their virus after receiving triple therapy of pegylated interferon, ribavirin, and boceprevir for 24 weeks. No patients in the study cohort discontinued treatment due to medication-related side effects.

Study results show that SIRS on admission and at 72 hours after is associated with a higher incidence of pancreatic necrosis, an important risk factor contributing to death in patients with severe acute pancreatitis.

A literature search found no well-documented evidence showing that implementing a gluten-and-casein-free diet in children with autism produces statistically significant differences in autism-related behaviors.

Two studies at the American College of Gastroenterology's 78th Annual Scientific Meeting analyzed the health outcomes of inflammatory bowel disease in the U.S. and Canada.

News and updates about the upcoming ACG 2013 annual meeting.

Pictures from the 2010 American College of Gastroenterology annual conference, which was held in San Antonio, TX.

It is vital that those caring for IBD patients evaluate for vitamin D nutritional deficiency.

Summaries of several studies presented during the Wednesday plenary session at ACG 2010.

A review of the data on risk of infection, malignancy, and death associated with therapies for IBD.

The past decade has seen increased use of TNF antagonists for the treatment of inflammatory bowel disease.

Six standout posters were presented on Tuesday that focused on Inflammatory Bowel Disease.

Seven standout studies were presented during this morning's plenary session.

What do gastroenterologists need to know before creating a website for their practice?

The need exists to achieve maximum efficieny in the endo suite while maintaining maximum qualty.

Coding issues remain a moving target in gastroenterology, and one must rely on other sources to remain up to date.

Seven poster presentations focused on ulcerative colitis during the Monday, October 18, poster presentations. Here, each is summarized.

Of the nearly 400 clinical vignettes and case reports presented on Monday, two focused on ulcerative colitis.